Schedule 13G ownership disclosure

Kura Oncology Inc

Security class unavailable · CUSIP: 50127T109

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
22,717,461
Percent of class
7.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001564590-18-001128
Form type
SC 13G/A
Filer
Kura Oncology, Inc.
CIK
CIK 1422143
Filed
Jan 31, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub